Advertisement

Renal Rescue: Management of Impending Renal Failure

  • J. Cordingley
  • M. Palazzo
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 1996)

Abstract

The development of acute renal failure (ARF) in patients with multiple organ system dysfunction (MODS) is associated with a high mortality upon which support with hemofiltration appears to have had little impact. The reason for this is unclear although complications such as hemorrhage, cardiovascular instability and prolongation of the course of renal dysfunction all play their part [1].

Keywords

Glomerular Filtration Rate Acute Renal Failure Atrial Natriuretic Peptide Renal Blood Flow Acute Tubular Necrosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Schiffl H, Lang S, Konig A, Strasser T, Haider M, Held E (1994) Biocompatible membranes in acute renal failure: Prospective case-controlled study. Lancet 344: 570–572PubMedCrossRefGoogle Scholar
  2. 2.
    Vincent JL (1994) Renal effects of dopamine: Can our dream ever come true? Crit Care Med 22: 5–6PubMedCrossRefGoogle Scholar
  3. 3.
    Thompson B, Cockrill B (1994) Renal — dose dopamine: A siren song? Lancet 344: 7–8PubMedCrossRefGoogle Scholar
  4. 4.
    Booke M, Armstrong C, Hinder F, Traber L, Traber D (1995) Propofol selectively reduces renal blood flow in sepsis Crit Care Med 23:A165 (Abst)Google Scholar
  5. 5.
    Fulda G (1990) Intraabdominal hypertension. Crit Care Report 1: 336–343Google Scholar
  6. 6.
    Harman P, Kron I, McLachlan H, et al (1982) Elevated intraabdominal pressure and renal function. Ann Surg 196: 594–597PubMedCrossRefGoogle Scholar
  7. 7.
    Collee G, Lomax D, Ferguson C, Hanson G (1993) Bedside measurements of intraabdominal pressure via an indwelling nasogastric tube: Clinical validation of the technique. Intensive Care Med 19: 478–480PubMedCrossRefGoogle Scholar
  8. 8.
    Aperia A, Bertorello A, Seri I (1987) Dopamine causes inhibition of Na+, K+-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 252: F39–F45PubMedGoogle Scholar
  9. 9.
    Olsen N, Lund J, Jensen P, et al (1993) Dopamine, dobutamine and dopexamine. A comparison of renal effects in unanesthetized human volunteers. Anesthesiol 79: 685–694CrossRefGoogle Scholar
  10. 10.
    Graves T, Cioffi W, Vaughan G, et al (1993) The renal effects of low-dose dopamine in thermally injured patients. J Trauma 35: 97–103PubMedCrossRefGoogle Scholar
  11. 11.
    Goldberg L (1972) Cardiovascular and renal implications of dopamine: Potential applications. Pharmacol Rev 24: 1–29PubMedGoogle Scholar
  12. 12.
    ter Wee P, Smit A, Rosman J, Sluiter W, Donker A (1986) Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease. Am J N ephrol 6: 42–46Google Scholar
  13. 13.
    Polson R, Park G, Lindop M, Farman J, Calne R, Williams R (1987) The prevention of renal impairment in patients undergoing orthoptic liver grafting by infusion of low dose dopamine. Anaesthesia 42: 15–19PubMedCrossRefGoogle Scholar
  14. 14.
    Swygert T, Roberts L, Valek T, et al (1991) Effect of intraoperative low-dose dopamine on renal function in liver transplant recipients. Anesthesiology 75: 571–576PubMedCrossRefGoogle Scholar
  15. 15.
    Parks R, Diamond T, McCrory D, Johnston G, Rowlands B (1994) Prospective study of postoperative renal function in obstructive jaundice and the effect of perioperative dopamine. Br J Surg 81: 437–439PubMedCrossRefGoogle Scholar
  16. 16.
    Baldwin L, Henderson A, Hickman P (1994) Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 120: 744–747PubMedGoogle Scholar
  17. 17.
    Henderson I, Beattie T, Kennedy A (1980) Dopamine hydrochloride in oliguric states. Lancet 2: 827–828PubMedCrossRefGoogle Scholar
  18. 18.
    Davis R, Lappas D, Kirklin J, Buckley M, Lowenstein E (1982) Acute oliguria after cardiopulmonary bypass: Renal functional improvement with low-dose dopamine infusion. Crit Care Med 10: 852–856PubMedCrossRefGoogle Scholar
  19. 19.
    Parker S, Carlon G, Isaacs M (1981) Dopamine administration in oliguria and oliguric renal failure. Crit Care Med 9: 630–632PubMedCrossRefGoogle Scholar
  20. 20.
    Lindner A (1983) Synergism of dopamine and furosemide in diuretic resistant oliguric acute renal failure. Nephron 33: 121–126PubMedCrossRefGoogle Scholar
  21. 21.
    Graziani G, Cantaluppi A, Casati S, et al (1984) Dopamine and frusemide in oliguric acute renal failure. Nephron 37: 39–42PubMedCrossRefGoogle Scholar
  22. 22.
    Lumlertgul D, Keoplung M, Sitprija V, Moolaor P, Suwangool P (1989) Furosemide and dopamine in malarial acute renal failure. Nephron 52: 40–44PubMedCrossRefGoogle Scholar
  23. 23.
    Cantarovich F, Fernandez J, Locatelli A (1971) Frusemide in high doses in the treatment of acute renal failure. Postgrad Med J 47: 13–17PubMedGoogle Scholar
  24. 24.
    Cantarovich F, Galli C, Benedetti L (1973) High dose frusemide in established acute renal failure. Br Med J 4: 449–450PubMedCrossRefGoogle Scholar
  25. 25.
    Kleinknecht D, Ganeval D, Gonzalez-Duque L, et al (1976) Furosemide in acute oliguric renal failure: A controlled trial. Nephron 17: 51–58PubMedCrossRefGoogle Scholar
  26. 26.
    Brown C, Ogg C, Cameron J (1981) High dose frusemide in acute renal failure: A controlled trial. Clin Nephrol 15: 90–96PubMedGoogle Scholar
  27. 27.
    Dawson J (1965) Post-operative renal function in obstructive jaundice: Effect of a mannitol diuresis. Br Med J 1: 82–86PubMedCrossRefGoogle Scholar
  28. 28.
    Gubern J, Sancho J, Simo J, Sitges-Serra A (1988) A randomized trial on the effect of mannitol on postoperative renal function in patients with obstructive jaundice. Surg 103: 39–44Google Scholar
  29. 29.
    Barry K, Cohen A, Knochel J, et al (1961) Mannitol infusion II. Prevention of acute functional renal failure during resection of an aneurysm of the abdominal aorta. New Engl J Med 264: 967–971PubMedCrossRefGoogle Scholar
  30. 30.
    Beall A, Holman M, Morris G, DeBakey M (1963) Mannitol-induced osmotic diuresis during vascular surgery. Arch Surg 86: 34–41Google Scholar
  31. 31.
    Paul M, Mazer C, Byrick R, Rose D, Goldstein M (1986) Influence of mannitol and dopamine on renal function during elective infrarenal aortic clamping in man. Am J Nephrol 6: 427–434PubMedCrossRefGoogle Scholar
  32. 32.
    Carmines P, Fleming J (1990) Control of the renal microvasculature by vasoactive peptides. FASEB J 4: 3300–3309PubMedGoogle Scholar
  33. 33.
    Lumertgul D, Hutdagoon M, Sirivanichai C, Keoplung M (1990) Beneficial effect of intrarenal verapamil in human acute renal failure. Renal Failure 11: 201–208CrossRefGoogle Scholar
  34. 34.
    Duggan K, GJ M, Charlesworth J, et al (1985) Verapamil prevents post-transplant oliguric renal failure. Clin Nephrol 7: 287–291Google Scholar
  35. 35.
    Wagner K, Albrecht S, Neumayer H-H (1987) Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: A prospective randomized study. Am J Nephrol 7: 287–291PubMedCrossRefGoogle Scholar
  36. 36.
    Pollock D, Opgenorth T (1993) Atrial natriuretic peptides in the treatment of acute renal failure. Renal Failure 15 : 439–449PubMedCrossRefGoogle Scholar
  37. 37.
    Ramamoorthy C, Rooney M, Dries D, Mathru M (1992) Aggressive hydration during continuous positive-pressure ventilation restores atrial transmural pressure, plasma atrial natriuretic peptide concentrations and renal function. Crit Care Med 20: 1014–1019PubMedCrossRefGoogle Scholar
  38. 38.
    Andrivet P, Adnot S, Sanker S, et al (1991) Hormonal interactions and renal function during mechanical ventilation and renal function and ANF infusion in humans. J Appl Physiol 70: 287–292PubMedGoogle Scholar
  39. 39.
    Conger J, Falk S, Yuan B, Schrier R (1989) Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. Kidney Int 35: 1126–1132PubMedCrossRefGoogle Scholar
  40. 40.
    Shaw S, Weidmann P, Hodler J, Zimmermann A, Paternostro A (1987) Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. J Clin Invest 80: 1232–1237PubMedCrossRefGoogle Scholar
  41. 41.
    Schafferhans K, Heibreder E, Sperber S, Dämmrich J, Heidland A (1988) Atrial natriuretic peptide in gentamicin-induced acute renal failure. Kidney Int 34: S101–S103Google Scholar
  42. 42.
    Gotz R, Bausewein K, Heidbreder E, et al (1989) Acute renal failure in the intensive care unit: Are there benefits of atrial natriuretic factor in dopamine/furosemide resistant acute renal failure? Kidney Int 35: 282 (Abst)Google Scholar
  43. 43.
    Sands J, Neylan J, Olson R, O’Brien D, Whelchel J, Mitch W (1991) Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation. J Am Soc Nephrol 1: 1081–1086PubMedGoogle Scholar
  44. 44.
    Rahman S, Kim G, Mathew A, et al (1994) Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 45: 1731–1738PubMedCrossRefGoogle Scholar
  45. 45.
    Saxenhofer H, Raselli A, Weidmann P, et al (1990) Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in man. Am J Physiol 259: F415–F418Google Scholar
  46. 46.
    Hummel M, Kuhn M, Bub A, et al (1993) Urodilatin, a new therapy to prevent kidney failure after heart transplantation. J Heart Lung Transpl 12: 209–217Google Scholar
  47. 47.
    Cedidi C, Meyer M, Kuse E, et al (1994) Urodilatin: A new approach for the treatment of therapy-resistant acute renal failure after liver transplantation. Eur J Clin Invest 24: 632–639PubMedCrossRefGoogle Scholar
  48. 48.
    Gomez-Jimenez J, Salgado A, Mourelle M, et al (1995) L-arginine/nitric oxide pathway in septicaemia and human septic shock. Crit Care Med 23: 253–258PubMedCrossRefGoogle Scholar
  49. 49.
    Bachmann S, Mundel P (1994) Nitric oxide in the kidney: Synthesis, localization and function. Am J Kidney Dis 24: 112–129PubMedGoogle Scholar
  50. 50.
    Petros A, Bennett E, Valance P (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338: 1557–1558PubMedCrossRefGoogle Scholar
  51. 51.
    Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M (1994) Nitric oxide and prostanoids protect the renal outer medulla from radio contrast toxicity in the rat. J Clin Invest 94 : 1069–1075PubMedCrossRefGoogle Scholar
  52. 52.
    Brezis M, Heyman S, Dinour D, Epstein F, Rosen S (1991) Role of nitric oxide in renal medullary oxygenation. J Clin Invest 88: 390–395PubMedCrossRefGoogle Scholar
  53. 53.
    Shultz P, Raij L (1992) Endogenously synthesized nitric oxide prevents endotoxininduced glomerular thrombosis. J Clin Invest 90: 1718–1725PubMedCrossRefGoogle Scholar
  54. 54.
    Booke M, Meyer J, Lingnau W, Hinder F, Traber L, Traber D (1995) Use of nitric oxide synthase inhibitors in animal models of sepsis. New Horizons 3: 123–138PubMedGoogle Scholar
  55. 55.
    Nord E (1993) Renal actions of endothelin. Kidney Int 44: 451–463PubMedCrossRefGoogle Scholar
  56. 56.
    Rabelink T, Kassjager K, Boer P, Stroes E, Braam B, Koomans H (1994) Effects of endothelin-Ion renal function in humans: Implications for physiology and pathophysiology. Kidney Int 46: 376–381PubMedCrossRefGoogle Scholar
  57. 57.
    Lin H, Sangmal M, Smith M, Young D (1993) Effect of endothelin-1 on glomerular hydraulic pressure and renin release in dogs. Hypertension 21: 845–851PubMedGoogle Scholar
  58. 58.
    Nassar G, Badr K (1994) Endothelin in kidney disease. Curr Opin Nephrol Hypertens 3: 86–91PubMedCrossRefGoogle Scholar
  59. 59.
    Tomita K, Ujiie K, Nakanishi T, et al (1989) Plasma endothelin levels in patients with acute renal failure. New Engl J Med 321: 1127PubMedGoogle Scholar
  60. 60.
    Kon V, Badr K (1991) Biological and patholophysiological significance of endothelin within the kidney. Kidney Int 40: 1–12PubMedCrossRefGoogle Scholar
  61. 61.
    Mino N, Kobayashi M, Nakajima A, et al (1992) Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats. Eur J Pharmacology 221: 77–83CrossRefGoogle Scholar
  62. 62.
    Morise Z, Ueda M, Aiura K, Endo M, Kitajima M (1994) Pathophysiologic role of endothelin-1 in renal failure in rats with endotoxin shock. Surg 115: 199–204Google Scholar
  63. 63.
    Heyman S, Clark B, Kaiser N, et al (1992) Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc N ephrol 3: 58–65Google Scholar
  64. 64.
    Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K (1992) Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. New Engl J Med 327: 1774–1778PubMedCrossRefGoogle Scholar
  65. 65.
    Bloom I, Bentley F, Garrison R (1993) Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1. Surg 114: 480–488Google Scholar
  66. 66.
    Kelleher S, Robinette J, Conger J (1984) Sympathetic nervous system in the loss of autoregulation in acute renal failure. Am J Physiol 246: F379–F386PubMedGoogle Scholar
  67. 67.
    Conger J, Schultz M, Miller F, Robinette J (1994) Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Int 46: 318–323PubMedCrossRefGoogle Scholar
  68. 68.
    Bersten A, Holt A (1995) Prevention of acute renal failure in the critically ill patient. In: Bellomo R, Ronco C (eds) Acute renal failure in the critically ill update in intensive care and emergency medicine. Springer-Verlag, Berlin, pp 122–146Google Scholar
  69. 69.
    Pullman T, McClure W (1954) The response of the renal circulation in man to constant speed infusions of I-norepinephrine. Circulation 9: 600–605PubMedGoogle Scholar
  70. 70.
    Desjars P, Pinaud M, Potel G (1987) A reappraisal of norepinephrine in human septic shock. Crit Care Med 15: 134–137PubMedCrossRefGoogle Scholar
  71. 71.
    Desjars P, Pinaud M, Bugnon D, Tasseau F (1989) Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 17: 426–429PubMedCrossRefGoogle Scholar
  72. 72.
    Hesselvik J, Brodin B (1989) Low dose norepinephrine in patients with septic shock and oliguria: Effects on afterload, urine flow, and oxygen transport. Crit Care Med 17: 179–180PubMedCrossRefGoogle Scholar
  73. 73.
    Cesare J, Ligas J, Hirvela E (1993) Enhancement of urine output and glomerular filtration in acutely oliguric patients using low-dose norepinephrine. Circ Shock 39: 207–210PubMedGoogle Scholar
  74. 74.
    Martin C, Papazian L, Perrin G, Saux P, Gouin F (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 103: 1826–1831PubMedCrossRefGoogle Scholar
  75. 75.
    Uehlinger D, Weidmann P, Gnaedinger M (1986) Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man. J Clin Endocrin Metab 63: 669–674CrossRefGoogle Scholar
  76. 76.
    Brenner M, Schaer G, Mallory D, Suffredini A, Parrillo J (1990) Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. Chest 98: 170–179PubMedCrossRefGoogle Scholar
  77. 77.
    Raper R, Rutledge F, Hobson J, Driedger A, Sibbald W (1987) Organ blood flow in high output normotensive sepsis. Crit Care Med 15: 440 (Abst)CrossRefGoogle Scholar
  78. 78.
    Aukland K, Krog J (1960) Renal oxygen tension. Nature 188: 671PubMedCrossRefGoogle Scholar
  79. 79.
    Brezis M, Rosen S, Silva P, Epstein F (1984) Renal ischaemia: A new perspective. Kidney Int 26: 375–383PubMedCrossRefGoogle Scholar
  80. 80.
    Brezis M, Rosen S, Silva P, Epstein F (1984) Transport activity modifies thick ascending limb damage in the isolated perfused kidney. Kidney Int 25: 65–72PubMedCrossRefGoogle Scholar
  81. 81.
    Brezis M, Agmon Y, Epstein F (1994) Determinants of intrarenal oxygenation I. Effects of diuretics. Am J Physiol 36: F1059–F1062Google Scholar
  82. 82.
    Silva P, Rosen S, Spokes K, Taylor M, Epstein F (1990) Influence of endogenous prostaglandins on mTAL injury. J Am Soc Nephrol 1: 808–814PubMedGoogle Scholar
  83. 83.
    Driscoll D, Pinson C, Jenkins R, Bistrian B (1989) Potential protective effects of furosemide against early renal injury in liver transplant patients receiving cyclosporine-A. Crit Care Med 17: 1341–1343PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • J. Cordingley
  • M. Palazzo

There are no affiliations available

Personalised recommendations